We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial, CSL Behring Australia Pty Ltd, CON-1340
Product name
ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial
Sponsor name
CSL Behring Australia Pty Ltd
Consent start
Consent no.
CON-1340
Duration
The consent is effective from 21 March 2025 until 1 October 2031.
Standard
Part 2, subsection 10(9) and Schedule 1, Item 14 of Therapeutic Goods (Standard for Human Cell and Tissue Products - Donor Selection Requirements) (TGO 108) Order 2021
Non-compliance with standard
The product does not comply with the requirement for at least a 2-week deferral
from the date of full recovery for a person who has a symptomatic infection,
fever or infectious illness for recurrent or subsequent Herpes Simplex Virus
(HSV) infection.
Import, Supply, &/or Export
supply
Therapeutic product type
Blood, tissues, and biologicals